Cargando…

In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([(189, 191)Pt]cisplatin) Emitting Auger Electrons

Due to their short-range (2–500 nm), Auger electrons (Auger e(−)) have the potential to induce nano-scale physiochemical damage to biomolecules. Although DNA is the primary target of Auger e(−), it remains challenging to maximize the interaction between Auger e(−) and DNA. To assess the DNA-damaging...

Descripción completa

Detalles Bibliográficos
Autores principales:	Obata, Honoka, Tsuji, Atsushi B., Sudo, Hitomi, Sugyo, Aya, Minegishi, Katsuyuki, Nagatsu, Kotaro, Ogawa, Mikako, Zhang, Ming-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124180/ https://www.ncbi.nlm.nih.gov/pubmed/33924843 http://dx.doi.org/10.3390/ijms22094622

Ejemplares similares

Synthesis of no-carrier-added [(188, 189, 191)Pt]cisplatin from a cyclotron produced (188, 189, 191)PtCl(4)(2−) complex
por: Obata, Honoka, et al.
Publicado: (2021)

Novel Auger-Electron-Emitting (191)Pt-Labeled Pyrrole–Imidazole Polyamide Targeting MYCN Increases Cytotoxicity and Cytosolic dsDNA Granules in MYCN-Amplified Neuroblastoma
por: Obata, Honoka, et al.
Publicado: (2023)

Development of Novel (191)Pt-Labeled Hoechst33258: (191)Pt Is More Suitable than (111)In for Targeting DNA
por: Obata, Honoka, et al.
Publicado: (2022)

Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice
por: Obata, Honoka, et al.
Publicado: (2022)

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice
por: Sudo, Hitomi, et al.
Publicado: (2019)

Low temperature nuclear orientation of $^{ 187,189,191}$Pt nuclei
por: Berkès, I, et al.
Publicado: (1976)

Measurements of quadrupole-interaction-resolved NMR on oriented 185Pt, 189Pt, and 191Pt in hcp-Co
por: Hinfurtner, B, et al.
Publicado: (1998)

Preclinical Evaluation of Podoplanin-Targeted Alpha-Radioimmunotherapy with the Novel Antibody NZ-16 for Malignant Mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2021)

Radiolabeled Human Monoclonal Antibody 067-213 has the Potential for Noninvasive Quantification of CD73 Expression
por: Sudo, Hitomi, et al.
Publicado: (2020)

High spin states in $^{189,191,193}$Au
por: Gono, Y, et al.
Publicado: (1976)

Cisplatin-Resistant CD44(+) Lung Cancer Cells Are Sensitive to Auger Electrons
por: Madsen, Karina Lindbøg, et al.
Publicado: (2022)

Evaluation of (89)Zr-Labeled Human Anti-CD147 Monoclonal Antibody as a Positron Emission Tomography Probe in a Mouse Model of Pancreatic Cancer
por: Sugyo, Aya, et al.
Publicado: (2013)

Levels in $^{189}$Ir studied in the decay of $^{189}$Pt
por: Hedin, G, et al.
Publicado: (1972)

Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model
por: Ohshima, Yasuhiro, et al.
Publicado: (2018)

α‐particle therapy for synovial sarcoma in the mouse using an astatine‐211‐labeled antibody against frizzled homolog 10
por: Li, Huizi Keiko, et al.
Publicado: (2018)

In vitro cytotoxicity of Auger electron-emitting [(67)Ga]Ga-trastuzumab
por: Othman, Muhamad Faiz bin, et al.
Publicado: (2020)

Controlling the influence of Auger recombination on the performance of quantum-dot light-emitting diodes
por: Bae, Wan Ki, et al.
Publicado: (2013)

Erratum. Genetics coming of age in type 1 diabetes. Diabetes Care 2019;42:189–191
por: Cerosaletti, Karen, et al.
Publicado: (2019)

Reducing the impact of Auger recombination in quasi-2D perovskite light-emitting diodes
por: Jiang, Yuanzhi, et al.
Publicado: (2021)

Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer
por: Sreekumar, Sreeja, et al.
Publicado: (2023)

Renin-angiotensin system inhibitors combined with cisplatin exacerbate cisplatin-induced nephrotoxicity in mice
por: Tsuji, Takumi, et al.
Publicado: (2022)

Proof of Concept Study for Increasing Tenascin-C-Targeted Drug Delivery to Tumors Previously Subjected to Therapy: X-Irradiation Increases Tumor Uptake
por: Sugyo, Aya, et al.
Publicado: (2020)

(111)In-BnDTPA-F3: an Auger electron-emitting radiotherapeutic agent that targets nucleolin
por: Cornelissen, Bart, et al.
Publicado: (2012)

Application of Geant4-DNA for simulating water radiolysis induced by Auger electron-emitting radionuclides
por: Adjei, Daniel, et al.
Publicado: (2023)

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy
por: Obata, Honoka, et al.
Publicado: (2023)

Spectro Auger
Publicado: (1995)

Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomains
por: Lv, Yao, et al.
Publicado: (2021)

Whole body retention in rats of different 191Pt compounds following inhalation exposure.
por: Moore, W, et al.
Publicado: (1975)

Exosomes loaded with ultrasmall Pt nanoparticles: a novel low-toxicity alternative to cisplatin
por: Sancho-Albero, María, et al.
Publicado: (2022)

Modular nanotransporters: a versatile approach for enhancing nuclear delivery and cytotoxicity of Auger electron-emitting (125)I
por: Slastnikova, Tatiana A, et al.
Publicado: (2012)

[(123)I]CC1: A PARP-Targeting, Auger Electron–Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer
por: Chan, Chung Ying, et al.
Publicado: (2023)

The Pierre Auger project
por: Mantsch, P M
Publicado: (1996)

The Pierre Auger Observatory
por: Swain, J D
Publicado: (2003)

Observatoire Pierre Auger
Publicado: (2009)

The theory of Auger transitions
por: Chattarji, D
Publicado: (1976)

Auger Prime Symposium
Publicado: (2015)

Therapeutic efficacy evaluation of radioimmunotherapy with (90)Y‐labeled anti‐podoplanin antibody NZ‐12 for mesothelioma
por: Sudo, Hitomi, et al.
Publicado: (2019)

Cisplatin induces stemness in ovarian cancer
por: Wiechert, Andrew, et al.
Publicado: (2016)

Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)

Therapeutic Efficacy of C-Kit-Targeted Radioimmunotherapy Using 90Y-Labeled Anti-C-Kit Antibodies in a Mouse Model of Small Cell Lung Cancer
por: Yoshida, Chisato, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eadidtoe0vis3bkqe71fic1cee